Sangamo Therapeutics - Stock Price History | SGMO

Historical daily share price chart and data for Sangamo Therapeutics since 2021 adjusted for splits. The latest closing stock price for Sangamo Therapeutics as of September 27, 2021 is 9.80.
  • The all-time high Sangamo Therapeutics stock closing price was 49.63 on September 01, 2000.
  • The Sangamo Therapeutics 52-week high stock price is 19.43, which is 98.3% above the current share price.
  • The Sangamo Therapeutics 52-week low stock price is 8.90, which is 9.2% below the current share price.
  • The average Sangamo Therapeutics stock price for the last 52 weeks is 11.60.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Sangamo Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 9.8276 8.2100 18.1800 5.0500 15.6050 86.44%
2019 10.3152 11.7800 13.0300 7.7200 8.3700 -27.09%
2018 16.3639 17.5500 26.3500 9.5100 11.4800 -30.00%
2017 9.1099 3.1000 17.3500 3.1000 16.4000 437.70%
2016 5.2740 8.9500 8.9500 2.7000 3.0500 -66.59%
2015 11.0198 15.2700 18.5400 5.5600 9.1300 -39.97%
2014 14.6635 13.7900 23.8600 9.8500 15.2100 9.50%
2013 9.7911 6.1500 14.3800 6.1500 13.8900 131.11%
2012 5.0402 2.9600 6.4900 2.9500 6.0100 111.62%
2011 5.6663 7.0500 8.6600 2.3600 2.8400 -57.23%
2010 4.7182 6.1400 7.1100 2.9600 6.6400 12.16%
2009 5.1817 3.6700 9.0300 2.7200 5.9200 70.11%
2008 9.3164 12.5400 13.6500 1.9500 3.4800 -73.27%
2007 10.0491 6.6000 19.0800 6.2200 13.0211 97.29%
2006 5.5784 4.1000 8.0000 4.1000 6.6000 63.77%
2005 4.3171 5.8000 5.8100 3.5400 4.0300 -32.83%
2004 5.3717 5.4900 8.0200 3.0000 6.0000 9.69%
2003 3.5860 3.4300 5.5000 2.4510 5.4700 81.73%
2002 5.5753 8.8900 10.2500 1.3000 3.0100 -67.77%
2001 12.5662 17.2500 24.6900 5.7000 9.3400 -52.10%
2000 24.9197 15.0600 49.6300 6.6250 19.5000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.424B $0.118B
Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc., formerly known as Sangamo BioSciences Inc., is based in Richmond, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29